Esber AL, Coakley P, Ake JA, Bahemana E, Adamu Y, Kiweewa F, Maswai J, Owuoth J, Robb ML, Polyak CS, Crowell TA on behalf of the AFRICOS Study Group. Decreasing time to antiretroviral therapy after HIV diagnosis in sub-Saharan Africa. Journal of the International AIDS Society. Feb 2020, 23:e25446. doi: 10.1002/jia2.25446. PMID: 32064776.
Crowell TA, Danboise B, Parikh A, Esber A, Dear N, Coakley P, Kasembeli A, Maswai J, Khamadi S, Bahemana E, Iroezindu M, Kiweewa F, Owuoth J, Freeman J, Jagodzinski LL, Malia JA, Eller LA, Tovanabutra S, Peel SA, Ake JA, Polyak CS on behalf of the AFRICOS Study Group. Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries. Clinical Infectious Diseases. 5 Oct 2021:ciaa1161. doi: 10.1093/cid/ciaa1161. PMID: 32785695.
Oluniyi P, Ajogbasile FV, Zhou S, Fred-Akintunwa I, Polyak CS, Ake JA, Tovanabutra S, Iroezindu M, Rolland M, Happi CT on behalf of the AFRICOS Study Group. HIV-1 Drug Resistance and Genetic Diversity in a Cohort of people living with HIV-1 in Nigeria. AIDS. 1 Jan 2022. 36:137-146. doi: 10.1097/QAD.0000000000003098. PMID: 34628443.
Esber A, Chang D, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Singoei V, Maswai J, Dear N, Crowell TA, Polyak CS, Ake JA on behalf of the AFRICOS Study Group. Modest Weight Gain During the Dolutegravir Transition in the African Cohort Study. Journal of the International AIDS Society. 25 Apr 2022. doi: 10.1002/jia2.25899. PMID: 35419973.
Esber A, Dear N, Shah N, Kibuuka H, Maswai J, Owuoth J, Singoei V, Bahemana E, Iroezindu M, Crowell TA, Polyak CS, Cavanaugh S, and Ake JA on behalf of the AFRICOS Study Group. Virologic impact of the dolutegravir transition: prospective results from the multinational African Cohort Study. JAIDS. 1 Nov 2022. 1;91(3):285-289. doi: 10.1097/QAI.0000000000003065. PMID: 35980350.
Reed DM, Esber AL, Crowell TA, Ganesan K, Kibuuka H, Maswai J, Owuoth J, Bahemana E, Iroezindu M, Ake JA, Polyak CS on behalf of the AFRICOS Study Group. Persons Living with HIV in Sero-discordant Partnerships Experience Improved HIV Care Outcomes Compared with Persons Living with HIV in Sero-concordant Partnerships in Four African Countries. AIDS Research and Therapy. 22 Jul 2021. 18(1):43. doi 10.1186/s12981-021-00363-x. PMID: 34294086.
Kibuuka H, Musingye E, Mwesigwa B, Semwogerere M, Iroezindu M, Bahemana E, Maswai J, Owuoth J, Esber A, Dear N, Crowell TA, Polyak CS, Ake JA on behalf of the AFRICOS Study Group. Predictors of All-Cause Mortality among People with HIV in a Prospective Cohort Study in East Africa and Nigeria. Clinical Infectious Diseases. 10 Sep 2022. doi: 10.1093/cid/ciab995/6448919. PMID: 34864933.